 price
thesi updat everyth play expect
doesnt quit mean thing run smoothli
profit expect straight year
core pharma hsd ldd due custom
renew kr well opioid-rel charg
furthermor medic tough given supplier charg
even adjust ramp ldd profit growth
seem aggress view thu manag
prudent
thing pay debt
restructur tough fight secular macro headwind
remain ever present given dynam expect today
ralli share short live particularli face
opioid-rel headlin like remain activ next
sever month share certainli expens
much view depend proport
believ impair given pend litig well
whether treat ultim fine settlement debt
remain cautiou draconian view
thu reiter rate pt move lower
includ npv hit bn relat upcom
litig would equat ebitda adjust
fine debt use methodolog broadli
cost suppli chain infrastructur
commod price imped progress
pleas see analyst certif import disclosur page report evercor isi affili seek busi
compani cover research report investor awar firm may conflict interest could affect object
report investor consid report singl factor make invest decis
path profit
declin profit part due chang relationship cordi supplier
mani issu creat nois medic
dont plan near term space focu execut
vigor defend also pursu area might make sens sharehold
use data autom etc achiev effici
mm save vs baselin
repay bn debt
custom renew fair appropri
full year impact
includ opioid tax medic devic tax major polici chang tariff etc
normal profit cadenc
primari contributor year vs result intern expect
relat exclus distribut agreement cordi supplier enter
valuat methodolog base mix discount cash flow analysi rel valuat multipl
risk valuat includ regulatori risk overal market risk well unforeseen event relat individu cover
compani broader sector includ new competit product technolog
laboratori corp america
articl articl
time dissemin august
analyst elizabeth anderson suzi yoon ross muken primarili respons prepar research report attest
follow view opinion render research report reflect person view subject compani
issuer part research analyst compens directli relat specif recommend view
research report
